Microbial Identification Market Size, Share, Growth, Statistics to 2033

14 May 2024

BioSpace

Share on XTweet

Microbial Identification Market Size, Share, Growth, Statistics to 2033 - read this article along with other careers information, tips and advice on BioSpace

According to Vision Research Reports, the global microbial identification market size was surpassed at USD 3.68 billion in 2023 and is expected to hit around USD 11.25 billion by 2033, growing at a CAGR of 11.82% from 2024 to 2033.

Importance of Microbial Identification

Understanding the identity of microorganisms is fundamental for several reasons. In healthcare, it aids in diagnosing infectious diseases, selecting appropriate treatments, and monitoring the effectiveness of interventions. In food production, microbial identification ensures product safety by detecting harmful pathogens. Additionally, in environmental science, identifying microbes helps assess ecosystem health and understand microbial roles in biogeochemical cycles.

Get Sample Copy of Report@ https://www.visionresearchreports.com/report/sample/41298

Report Highlights:

North America dominated the global market in 2023, holding the largest share at 39%.
In terms of Product & Services, the consumables segment secured the top position with a market share of 37% in 2023.
The software and services segment, categorized by Product & Services, is projected to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2033.
Within the realm of Technology, the PCR segment claimed the largest revenue share in 2023.
Next-generation sequencing (NGS), under the Technology category, is expected to experience a notable CAGR of 14.75% from 2024 to 2033.
Among different Methods, the genotypic segment held the majority market share of 42% in 2023.
Clinical diagnostics emerged as the leading Application segment, capturing the maximum market share in 2023.
End-use analysis revealed that hospitals and diagnostic laboratories secured the highest market share of 36% in 2023.

Immediate Delivery Available, Get Full Access@ https://www.visionresearchreports.com/report/checkout/41298

Microbial Identification Market Top Trends:

Advancements in technology: There has been a continual development of new and improved methods for identifying microorganisms. These advancements include:

Molecular biology techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and DNA microarray allow for rapid and precise identification of microorganisms based on their genetic profiles.
Bioinformatics tools and databases are crucial for handling the vast amounts of complex data generated by sequencing and mass spectrometry techniques. These tools enable researchers to interpret and analyze microbial genomes and proteomes with unprecedented accuracy and efficiency.
Automation and robotics are being integrated into microbial identification systems to streamline workflow processes, reduce human error, and increase throughput, making microbial identification more efficient and scalable.

Increasing prevalence of infectious diseases: The rise of antibiotic resistance and the emergence of new infectious diseases are driving the demand for rapid and accurate microbial identification. This allows for early diagnosis and treatment, which can improve patient outcomes and help to control the spread of infection.
Growing food safety concerns: Foodborne illnesses are a major public health concern, and the need for accurate and rapid identification of microbial contaminants in food is essential for ensuring food safety. Microbial identification technologies are being used to detect and identify pathogens in food products throughout the production chain, from farm to fork.
Antimicrobial resistance: The increasing prevalence of antimicrobial resistance (AMR) is a major global health challenge. The ability to quickly and accurately identify resistant microorganisms is critical for the development of new antibiotics and the implementation of effective infection control measures.

Methods of Microbial Identification:

Microbial identification involves the process of determining the specific types and characteristics of microorganisms present in a sample. Various methods are used for microbial identification, ranging from traditional techniques based on observable characteristics to modern molecular methods that analyze genetic material. Here are some commonly used methods:

Traditional Methods: Traditional methods rely on observing morphological characteristics and conducting biochemical tests to identify microorganisms. These methods are often the first step in microbial identification and include:
- Morphological Characteristics: Microbiologists use microscopy to observe the size, shape, and arrangement of microbial cells. These observations provide initial clues about the identity of the microorganism. For example, the shape of bacterial cells (e.g., cocci, bacilli, spirilla) can help differentiate between different bacterial species.
- Biochemical Tests: Biochemical tests involve assessing the metabolic capabilities of microorganisms by measuring their ability to utilize specific substrates or produce particular byproducts. These tests are based on the principle that different microorganisms have unique metabolic pathways. For example, the ability of bacteria to ferment sugars or produce specific enzymes can be used to identify them.
Modern Molecular Techniques: Modern molecular techniques have revolutionized microbial identification by analyzing genetic material, such as DNA or RNA. These methods offer greater specificity and accuracy compared to traditional techniques and include:
- Polymerase Chain Reaction (PCR): PCR is a molecular technique used to amplify specific regions of microbial DNA. By targeting and amplifying DNA sequences unique to certain microorganisms, PCR enables rapid detection and identification of pathogens. This technique is widely used in clinical diagnostics, research, and environmental monitoring.
- DNA Sequencing: DNA sequencing involves determining the nucleotide sequence of a DNA molecule. By sequencing the entire genome or specific genetic regions of a microorganism, scientists can compare the sequences to databases and identify the exact species or strain present in a sample. DNA sequencing provides the most accurate method for microbial identification and is commonly used in research and clinical settings.

Applications of Microbial Identification:

Healthcare: In the healthcare sector, microbial identification is essential for diagnosing infectious diseases. By identifying the specific pathogens responsible for infections, healthcare professionals can prescribe appropriate treatments, such as antibiotics or antiviral medications. Additionally, microbial identification plays a crucial role in monitoring antimicrobial resistance, helping healthcare providers select the most effective medications for patients.
Food Safety: In the food industry, microbial identification is critical for ensuring the safety and quality of food products. Foodborne pathogens, such as Salmonella, E. coli, and Listeria, can cause serious illness if consumed in contaminated food. By identifying these pathogens through microbial testing, food manufacturers can implement measures to prevent contamination and ensure that their products meet regulatory standards.
Environmental Monitoring: Environmental microbiologists use microbial identification to study microbial communities in various ecosystems, such as soil, water, and air. By identifying the types of microorganisms present in these environments, scientists can assess ecosystem health and understand the roles of microbes in biogeochemical processes, such as nutrient cycling and decomposition. This information is valuable for conservation efforts and environmental management.
Biotechnology and Pharmaceutical Research: Microbial identification is also important in biotechnology and pharmaceutical research. Microorganisms are used in various biotechnological processes, such as the production of enzymes, antibiotics, and biofuels. By accurately identifying microbial strains, researchers can optimize these processes and develop new products with specific characteristics. Additionally, microbial identification is essential for quality control in pharmaceutical manufacturing, ensuring that products are free from contamination.
Forensic Science: In forensic science, microbial identification can be used to analyze microbial evidence found at crime scenes. Microbial DNA recovered from biological samples, such as blood or saliva, can provide valuable information about the individuals involved in a crime. Microbial identification techniques, such as DNA sequencing, can help forensic investigators link suspects to crime scenes or identify unknown individuals.

U.S. Microbial Identification Market Size 2024 to 2033

The U.S. microbial identification market size was valued at around USD 1.07 billion in 2023 and is projected to hit around USD 3.29 billion by 2033, growing at a CAGR of 11.88% from 2024 to 2033.

In 2023, the North American market for microbial identification dominated with a market share of 39%. This significant share can be attributed to several factors, including the rising prevalence of infectious diseases, the presence of key market players, and a well-established healthcare infrastructure. Notably, in January 2022, BD received FDA 510(k) clearance for the BD Kiestra IdentifA system, an automated platform designed to streamline the process of microbiology bacterial identification testing sample preparation.

Furthermore, there is an increasing focus on food safety by government and regional authorities, leading to the adoption of microbial identification techniques for identifying and tracing microbes in food products. For instance, according to a June 2022 article in PubMed, various organizations at the federal, state, and local levels play distinct roles in formulating, implementing, and enforcing food safety regulations in the U.S. Therefore, ensuring effective collaboration among these entities is crucial for maintaining food safety standards. These factors are expected to drive further growth in the microbial identification market in the North American region.

Product & Services Insights

In 2023, the consumables segment claimed the largest market share of 37%. Within the microbial identification industry, consumables encompass vital items like culture media, reagents, and test kits, which require frequent replenishment. Laboratories and research facilities depend on a consistent supply of these consumables to conduct microbial identification tests. This ongoing need for replacement ensures a stable revenue stream for manufacturers and suppliers. For instance, in August 2023, Lovibond introduced test kits tailored for industrial applications. With a growing emphasis on water resource management and corresponding legal mandates, Lovibond aims to offer comprehensive solutions addressing specific needs and enabling precise water analyses. These product launches are expected to drive the growth of the segment.

The software and services segment are anticipated to exhibit the highest compound annual growth rate (CAGR) from 2024 to 2033. Software solutions have become increasingly important in microbial identification, with advanced data analytics, including machine learning and artificial intelligence, employed to analyze and interpret data generated during identification processes. This advancement holds the promise of delivering more accurate and efficient results, which are crucial for applications like clinical diagnostics, food safety, and environmental monitoring. Consequently, the segment is poised to experience significant growth within the microbial identification industry throughout the forecast period.

Technology Insights

In 2023, the PCR segment emerged as the market leader, commanding the largest share. This can be attributed to PCR's exceptional precision, speed, and versatility in detecting and identifying microorganisms. PCR enables the amplification of specific DNA sequences, making it highly sensitive and capable of detecting even minute amounts of microbial DNA. Its widespread adoption in clinical diagnostics, research laboratories, and various industries stems from its ability to swiftly and accurately identify pathogens. PCR plays a crucial role in disease diagnosis, food safety, and environmental monitoring. In August 2022, Bruker Corporation introduced advancements to its MALDI Biotyper (MBT) platform, unveiling novel multiplex PCR infectious disease assays that leverage its exclusive LiquidArray technology. This innovation significantly propelled the growth of the PCR segment.

The next-generation sequencing (NGS) segment is poised to exhibit the highest compound annual growth rate (CAGR) of 14.75% from 2024 to 2033. NGS technologies enable the sequencing of entire genomes, facilitating highly accurate species identification, even at the strain level. This granular level of analysis is critical in various fields, including clinical diagnostics, epidemiology, and research. In January 2023, Charles River introduced Accugenix Next-Gen Sequencing for Bacterial and Fungal Identification, a pioneering sequencing solution integrated into the Accugenix portfolio of microbial testing services.

Method Insights

In 2023, the genotypic segment led the market, capturing the largest share at 42%. This segment is anticipated to register the highest compound annual growth rate (CAGR) from 2024 to 2033. Genotypic methods, including DNA sequencing and DNA fingerprinting techniques, provide exceptional accuracy and specificity in microbial identification. By identifying microorganisms at the genetic level, these methods often yield more precise results compared to phenotypic approaches. Moreover, genotypic methods find applications across various sectors, such as clinical diagnostics, epidemiological studies, environmental assessments, and microbial diversity research. The extensive utility of genotypic methods across diverse applications has been a significant driver behind the segment's growth in the market.

Furthermore, the increasing adoption of precision medicine, which tailors medical treatments based on individual patient characteristics, has bolstered the demand for genotypic identification. A comprehensive understanding of the genetic composition of microorganisms is essential for devising personalized treatment strategies. Consequently, this trend is expected to further fuel the growth of the genotypic segment in the microbial identification market throughout the forecast period.

Application Insights

In 2023, the clinical diagnostics segment emerged as the leader in market share. The increasing prevalence of infectious diseases is expected to be a primary driver propelling the growth of this segment. Furthermore, advancements in molecular biology techniques, such as PCR and next-generation sequencing, are projected to significantly enhance the speed and accuracy of microbial identification in clinical settings. These technological advancements, coupled with the escalating incidence of infectious diseases, are poised to drive growth within the clinical diagnostics segment, ultimately leading to more efficient and accessible healthcare solutions. Consequently, the market is anticipated to experience growth from 2024 to 2033.

The pharmaceuticals segment is forecasted to exhibit the highest compound annual growth rate (CAGR) of 14.85% from 2024 to 2033. The pharmaceutical industry plays a crucial role in developing treatments and vaccines for emerging infectious diseases. Accurate and rapid microbial identification is imperative during epidemic outbreaks, making it a significant driver for the pharmaceutical sector. With the prevalence of infectious diseases on the rise, the pharmaceutical segment is expected to witness substantial growth within the microbial identification market over the forecast period.

End-use Insights

In 2023, the hospitals and diagnostic laboratories segment held the largest market share at 36%. This dominance can be attributed to the high patient volume and the diverse range of clinical scenarios encountered, which consistently drive the demand for microbial identification services. The necessity for rapid and accurate identification of pathogens further solidifies the market share of hospitals and diagnostic laboratories in the microbial identification industry.

On the other hand, the pharmaceutical and biotechnology companies’ segment is projected to exhibit the highest compound annual growth rate (CAGR) over the forecast period. These sectors play pivotal roles in developing treatments and vaccines for emerging infectious diseases. Rapid and precise microbial identification is indispensable for early detection and containment of outbreaks, as demonstrated during events like the COVID-19 pandemic. Therefore, this anticipated need is expected to significantly propel the growth of the pharmaceutical and biotechnology companies’ segment from 2024 to 2033.

Microbial Identification Market Key Companies

bioMérieux SA
Becton, Dickinson and Company
ThermoFisher Scientific Inc.
Bruker Corporation
Danaher Corporation
Qiagen N.V.
Charles River Laboratories
Wickham Micro Limited
VWR International LLC. (Avantor Inc.)
Comp10
Shimadzu Corporation
Merck KGaA
Eurofins Scientific SE
Biolog Inc

Recent Market News

In July 2023, Eurofins Scientific unveiled the expansion of its microbial laboratory in Texas, a move set to bolster the growth of the microbial identification market over the forecast period.
In May 2023, Merck KGaA made a significant investment of around €35 million (USD 38.35 million) for biosafety testing at its facilities in Glasgow and Stirling, Scotland. This investment is aimed at enhancing biosafety testing, a critical stage in the drug development and manufacturing process, to ensure the safety, efficacy, and regulatory compliance of pharmaceuticals.
Also in May 2023, Charles River announced the launch of its Next Generation Sequencing Services, Accugenix NGS, with a focus on bacterial and fungal identification. This service is expected to provide crucial information to pharmaceutical manufacturers regarding microbial control.

Microbial Identification Market Segmentation:

By Product & Services

Instruments
- Mass Spectrometers
- PCR Systems
- Microarrays
- Others
Consumables
- Reagents & Kits
- Plates & Media
Software & Services
- Identification Services
- Culture Collection Services
- Assay Validation Services